Literature DB >> 24214103

Characterizing the role of PCDH9 in the regulation of glioma cell apoptosis and invasion.

Chunlin Wang1, Bangbao Tao, Shiting Li, Bing Li, Xiaoqiang Wang, Guohan Hu, Weiqing Li, Yuhong Yu, Yicheng Lu, Jiachuan Liu.   

Abstract

PCDH9, a member of the protocadherin superfamily, is frequently lost in many different cancer types. This study aimed to detect PCDH9 expression in glioma tissues. This study also assessed the effects of PCDH9 expression in two different glioma cell lines. This was accomplished by manipulating PCDH9 expression in these glioma cell lines. The data showed that the expression of PCDH9 mRNA and protein was significantly decreased in gliomas compared to normal brain tissues. Lentivirus carrying PCDH9 cDNA restored PCDH9 expression in the U87 and U251 glioma cell lines. PCDH9 restoration in these cell lines reduced tumor cell viability, induced apoptosis, and caused G0/G1 cell cycle arrest. PCDH9 expression also suppressed the colony formation ability and invasion capacity of U87 and U251 cells. Molecularly, the restoration of PCDH9 expression upregulated Bax protein expression, but downregulated Bcl-2 and cyclin D1 expression. These data from the current study suggest that the loss of PCDH9 expression could contribute to glioma development and/or progression. Further studies will evaluate PCDH9 expression as a biomarker for the early detection of gliomas and as a prognostic indicator for this cancer type.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24214103     DOI: 10.1007/s12031-013-0133-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  23 in total

Review 1.  Brain tumors.

Authors:  L M DeAngelis
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Gamma-protocadherins are targeted to subsets of synapses and intracellular organelles in neurons.

Authors:  Greg R Phillips; Hidekazu Tanaka; Marcus Frank; Alice Elste; Lazar Fidler; Deanna L Benson; David R Colman
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

Review 4.  Malignant gliomas in adults.

Authors:  Patrick Y Wen; Santosh Kesari
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

5.  Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.

Authors:  J Ying; H Li; T J Seng; C Langford; G Srivastava; S W Tsao; T Putti; P Murray; A T C Chan; Q Tao
Journal:  Oncogene       Date:  2006-02-16       Impact factor: 9.867

6.  PCDH24-induced contact inhibition involves downregulation of beta-catenin signaling.

Authors:  Rui Ose; Toshihide Yanagawa; Shun Ikeda; Osamu Ohara; Hisashi Koga
Journal:  Mol Oncol       Date:  2008-11-06       Impact factor: 6.603

7.  Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation.

Authors:  Noriko Okazaki; Naomi Takahashi; Shin-Ichi Kojima; Yasuhiko Masuho; Hisashi Koga
Journal:  Carcinogenesis       Date:  2002-07       Impact factor: 4.944

Review 8.  Chemotherapeutic options for primary brain tumors.

Authors:  Lyndon Kim; Michael Glantz
Journal:  Curr Treat Options Oncol       Date:  2006-11

9.  Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization.

Authors:  M J Stassar; G Devitt; M Brosius; L Rinnab; J Prang; T Schradin; J Simon; S Petersen; A Kopp-Schneider; M Zöller
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  11 in total

Review 1.  Beyond E-cadherin: roles of other cadherin superfamily members in cancer.

Authors:  Frans van Roy
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

Review 2.  Role of RNA modifications in cancer.

Authors:  Isaia Barbieri; Tony Kouzarides
Journal:  Nat Rev Cancer       Date:  2020-04-16       Impact factor: 60.716

Review 3.  Aberrant expression and functions of protocadherins in human malignant tumors.

Authors:  Ming Shan; Yonghui Su; Wenli Kang; Ruixin Gao; Xiaobo Li; Guoqiang Zhang
Journal:  Tumour Biol       Date:  2016-07-24

4.  Targeting MIR155HG in glioma: a novel approach.

Authors:  Veerakumar Balasubramaniyan; Krishna P Bhat
Journal:  Neuro Oncol       Date:  2017-09-01       Impact factor: 12.300

5.  Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascade.

Authors:  Veronique G LeBlanc; Marlo Firme; Jungeun Song; Susanna Y Chan; Min Hye Lee; Stephen Yip; Suganthi Chittaranjan; Marco A Marra
Journal:  J Pathol       Date:  2017-04-26       Impact factor: 7.996

6.  Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas.

Authors:  Chunlin Wang; Qi Chen; Shu Li; Shiting Li; Zhenyu Zhao; Hongliang Gao; Xiaoqiang Wang; Bin Li; Wenchuan Zhang; Yan Yuan; Linzhao Ming; Hua He; Bangbao Tao; Jun Zhong
Journal:  Oncotarget       Date:  2017-02-07

7.  LINE-2 transposable elements are a source of functional human microRNAs and target sites.

Authors:  Rebecca Petri; Per Ludvik Brattås; Yogita Sharma; Marie E Jönsson; Karolina Pircs; Johan Bengzon; Johan Jakobsson
Journal:  PLoS Genet       Date:  2019-03-13       Impact factor: 5.917

Review 8.  Cadherin Signaling in Cancer: Its Functions and Role as a Therapeutic Target.

Authors:  Weina Yu; Li Yang; Ting Li; Yi Zhang
Journal:  Front Oncol       Date:  2019-10-04       Impact factor: 6.244

9.  Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma.

Authors:  Yanqin Wu; Shuhui Zheng; Jiayan Yao; Minrui Li; Guang Yang; Ning Zhang; Shenghong Zhang; Bihui Zhong
Journal:  Oncotarget       Date:  2017-01-10

10.  New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines.

Authors:  Monika Świerczewska; Andrzej Klejewski; Maciej Brązert; Dominika Kaźmierczak; Dariusz Iżycki; Michał Nowicki; Maciej Zabel; Radosław Januchowski
Journal:  Molecules       Date:  2018-04-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.